NCT06325527 · NOT YET RECRUITING
Cognitive Impairment Cohort Study of the Elderly Population in YuGarden
This is an observational study, not a treatment trial. Researchers in Shanghai are following roughly 600 elderly community residents over 8 years, tracking who develops mild cognitive impairment or Alzheimer's disease and why. No drug or intervention is being tested. The goal is to build a model that might predict cognitive decline earlier. Details on enrollment size and biomarker specifics are limited in the public summary.
You may qualify if
- The participants are community-dwelling elderly people living in Yuyuan community, Shanghai, aged 60-85 years old, with no gender restriction.
- Non-AD patients.
- The participants can complete the cognitive tests, biological sample collection, speech tests, neuroimaging examinations, and cooperate with the implementation of the whole process of research.
- The participants agree to participate in this study and sign the informed consent form.
You're excluded if
- Participants who are suffering from severe mental illness, tumor cachexia, severe liver and kidney dysfunction and other serious physical diseases and unable to cooperate with the examination.
- Participants who have visual or auditory impairment that hampers the completion of related examination.
- Situations when magnetic resonance imaging or other examinations are contraindicated.
The sponsor's own eligibility wording, lightly reformatted. The study team makes the final eligibility decision — worth discussing with your doctor.
Eligibility criteria as of 2024-03-22